MedPath

Ifinatamab deruxtecan

Generic Name
Ifinatamab deruxtecan
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
2484870-92-8
Unique Ingredient Identifier
C6I0GC0GX5
Associated Conditions
-
Associated Therapies
-

A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

Phase 1
Recruiting
Conditions
Extensive Stage-small Cell Lung Cancer
Interventions
First Posted Date
2024-04-12
Last Posted Date
2025-01-08
Lead Sponsor
Daiichi Sankyo
Target Recruit Count
123
Registration Number
NCT06362252
Locations
🇫🇷

Assistance Publique-Hă"Pitaux de Marseille, Marseille, France

🇫🇷

Chu Nantes - Hă"Pital Guillaume Et Renă Laă<Nnec, Saint Herblain, France

🇫🇷

Hă"Pital Foch, Suresnes Cedex, France

and more 46 locations
© Copyright 2025. All Rights Reserved by MedPath